ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

RAFAEL MARTINEZ M.D.

315 N SAN SABA SUITE 103

San antonio | Texas | 78207

(210) 738-8222

Incorrect Info?
Search this name in Dollars for Docs »

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,772Medicare Part D Prescriptions Filled, Including Refills

Rank: 704 out of 4623

$3.54M Total Retail Price of All Prescriptions

Rank: 3 out of 4623

316 Patients Receiving at Least One Drug in Part D
20%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 316 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

34% of this provider’s 316 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 1,113 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

50% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$403 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
TRUVADA 709 19 10 1 201
HYDROCODONE-ACETAMINOPHEN 648 34 S3 2 3
NORVIR 431 0 3 210
ATRIPLA 336 0 4 272
PREZISTA 233 0 5 253
REYATAZ 224 0 6 302
ISENTRESS 206 12 7 257
INTELENCE 195 0 8 388
NEXIUM 179 39 9 17
ZOLPIDEM TARTRATE 161 30 10 18
KALETRA 142 0 11 358
SULFAMETHOXAZOLE-TRIMETHOPRIM 129 0 12 68
GABAPENTIN 116 0 13 16
OMEPRAZOLE 106 12 14 7
SINGULAIR 100 0 15 83
CITALOPRAM HBR 87 0 16 23
METFORMIN HCL 83 0 17 6
AZITHROMYCIN 81 12 18 33
PRAVASTATIN SODIUM 80 33 19 11
FLUTICASONE PROPIONATE 77 24 20 32
CYMBALTA 76 13 21 48
LISINOPRIL 74 11 22 4
COMPLERA 72 0 23 499
VALACYCLOVIR 72 0 23 366
AMLODIPINE BESYLATE 72 23 23 5
EPZICOM 71 0 26 373
BACLOFEN 70 16 27 133
ENALAPRIL MALEATE 70 16 27 41
SERTRALINE HCL 69 12 29 26
TRAZODONE HCL 68 0 30 42
TRAMADOL HCL 64 15 31 15
LOVAZA 61 0 32 112
MONTELUKAST SODIUM 60 0 33 158
OXYCONTIN 60 0 S2 33 267
MELOXICAM 59 11 35 27
METOPROLOL SUCCINATE 56 17 36 13
HYDROCHLOROTHIAZIDE 56 13 36 10
METOPROLOL TARTRATE 50 24 38 9
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 27, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.